MedTrace Logo

Copenhagen, Boston, Sydney

NCT04178603 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2022-01-06

No results posted yet for this study

Summary

The study investigates the regulation of muscle glucose utilization during exercise and enhanced insulin sensitivity in recovery from exercise.

This will be investigated in lean control subjects and obese insulin resistant subjects.

Conditions

Interventions

OTHER

Exercise, insulin infusion

Trial A: Acute one-legged exercise Trial B: Insulin infusion 4 hours after one-legged exercise

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • University of Sydney

    collaborator OTHER

  • University of Copenhagen

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-05
Primary Completion
2020-09-01
Completion
2020-09-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04178603 on ClinicalTrials.gov